News

Merck and Baylor College of Medicine collaborate to advance COVID-19 vaccine manufacturing platform

The Merck-Baylor teams will improve the manufacturing platform for the CoV RBD219-N1 vaccine candidate, which was originally developed to target SARS in 2011-2016.

Read More

May 28, 2020

By : Team ABLE

CSIR-IIIM & Reliance Industries to develop RT-LAMP based test for Coronavirus

RT-LAMP a rapid, accurate and cost-effective test can be done with indigenous components and set up with minimal expertise and instrumentation

Read More

May 27, 2020

By : Team ABLE

Biocon Biologics gets DCGI nod for blood purification device to treat COVID-19 patients

India’s drug regulator, DCGI has approved CytoSorb, an extracorporeal blood purification (EBP) device, developed by Biocon Biologics,to reduce pro-inflammatory cytokines levels in confirmed COVID patients with confirmed or imminent respiratory failure.

Read More

May 27, 2020

By : Team ABLE

US FDA approves intravenous artesunate to treat severe malaria

Prior to this approval, IV artesunate was only available to patients through the FDA's Expanded Access program, which allowed the U.S. CDC to provide IV artesunate to U.S. patients with severe malaria

Read More

May 27, 2020

By : Team ABLE

Boehringer Ingelheim, Eli Lilly to collaborate with Duke Institute for heart disease research

The collaboration will investigate whether empagliflozin can improve outcomes and prevent heart failure in adults with and without diabetes

Read More

May 27, 2020

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights